About
Cannabinoid for Alzheimer's
Areas of Focus
Categories
Small Molecule PharmaceuticalCannabis & MarijuanaVirginia, DC, DE & Maryland
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
2
As Collaborator
2
Total Enrollment
544
By Phase
PHASE2: 2PHASE1: 1PHASE4: 1
By Status
COMPLETED: 3RECRUITING: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05543681Lead Sponsor
Clinical Trial on Agitation in Alzheimer's Dementia
PHASE2Recruiting
164 participants
Started: Oct 11, 2022 · Completed: Mar 30, 2026
NCT04610138Collaborator
Study of ZnAg Liquid Solution to Treat COVID-19 Symptomatic Participants
PHASE2Completed
296 participants
Started: Jun 1, 2021 · Completed: Oct 20, 2022
NCT04749563Lead Sponsor
Study of IGC-AD1 in Subjects With Dementia Due to Alzheimer's Disease
PHASE1Completed
12 participants
Started: Jan 11, 2021 · Completed: Jun 20, 2021
NCT04184401Collaborator
Effect of Ascites Replacement Strategy on Time to 1st Flatus After LDLT
PHASE4Completed
72 participants
Started: Jan 1, 2020 · Completed: Nov 30, 2021
Locations (1)
Headquarters
Potomac, MD, United States
Map
Loading map...